City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Lily Lai, MD  
Search results:  4  Clinical trial(s) found  (Page 1 of 1 )
 
Click here to generate a printer-friendly view  
 09131
   P.I.: Lily Lai, MD
Title: NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
 
Click here for  Full Eligibility Criteria
 08005
   P.I.: Lily Lai, MD
Title: Phase I Study of Ursodeoxycholic Acid in Combination with 5-Fluorouracil, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Metastatic Colorectal Cancer
 
Click here for  Full Eligibility Criteria
 06210
   P.I.: Lily Lai, MD
Title: ECOG E5202: A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
 
Click here for  Brief Eligibility Criteria
 Full Eligibility Criteria
 04197
   P.I.: Lily Lai, MD
Title: NSABP R-04: A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion (CVI) of 5-Fluorouracil (5-FU) in the Treatment of Patients with Operable Carcinoma of the Rectum
 
Click here for  Brief Eligibility Criteria
 Full Eligibility Criteria
 

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.